BACKGROUND: This research aims to retrospectively evaluate the effectiveness and safety of dermal substitute (DS), Nevelia ® , for the treatment of severely burned patients.
INTRODUCTION
The principle of care in managing severely burned patients is primarily focused on survival. The main issues in the first hours are resuscitation and haemodynamics. After 48 hours, septic problems and eschar management eventually become a critical issue. The insufficiency of skin graft donor sites in severely burned patients is one of the major problems in the management of these patients.
Dermal substitutes (DS) are becoming an important part of burn care with an increasing interest. In the acute phase of Yiğitbaş et al. Our experience with DS Nevelia® in the treatment of severely burned patients Nevelia ® (Symatese Aesthetics, Lyon, France) is made from specific native collagen with a large fibrous proportion to preserve cell adhesion signals and mechanical structure to support regeneration. In vitro test demonstrate an optimised colonisation as fibroblasts recognise collagen fibres. Nevelia ® is indicated for dermal regeneration in cases involving skin loss, particularly in burns and trauma. This bi-layer matrix is usually used in combination with a thin split-thickness skin graft (STSG) to recreate skin resembling the normal one in terms of function and appearance. This research describes our experience in using Nevelia ® for the treatment of severely burned patients.
MATERIALS AND METHODS
This retrospective case series study was approved by the Health Sciences University, Bağcılar Education and Research Hospitals' Ethics Committee. This study included patients who were admitted to a burn care unit with severe fullthickness burn wounds [Total Body Surface Area (TBSA) ≥25%] between May 2017 and May 2018. Their need for surgery, complications, hospitalisation duration and overall survival were analysed. TBSA percentage and TBSA with Nevelia ® surface were measured using the Lund and Browder chart. [5] Burn patients were categorised according to a specific clinical burn management protocol designed to stabilise them within 48 to 72 hours. Later, using the SPY ® Infrared Fluo-rescence Imaging System (Novodaq, Stryker, US), burn depth was measured. According to the patient's clinical state and tolerance, viable and healthy dermis were protected. Chemical eschar debridement and reepithelisation procedures were performed. In burn areas that were not too deep, self-healing procedures were followed. In areas with a third-degree burn, early eschar excision protocol was used. Then, Nevelia ® was applied to the escharotomy areas.
Nevelia ® was applied on the burn area using ApposeTM Single-Use Skin Stapler (Medtronic, MN, USA) and was dressed with antimicrobial materials. The dressing was changed every two days. Integration of the Nevelia ® to the tissues was observed during this time.
The subsequent delamination of Nevelia ® (silicone leaf removal) and the timing of split-thickness skin graft application were determined on a case-to-case basis according to the availability and physiological well-being of the subject. Re-harvesting from the same donor site was necessary for some patients. Therefore, the state of re-epithelialization of the skin graft donor site was very important for them. Once delaminated, the surface of the neodermis was refreshed by dermabrasion before meshed STSG was applied and the dressing was performed.
The thickness of harvest and mesh ratio of the STSG was determined clinically on each occasion by donor site availability, and the need for the second harvest from the same donor areas was anticipated. In this study, all grafts applied over Nevelia ® were either applied as fenestrated sheet graft (over the dorsum of hands) or meshed 1,5-3, at all other sites. Skin grafts were dressed according to our previous standard of care, typically with paraffin gauze overlaid with saline and antibacterial-soaked gauze secured with crepe bandages. Dressings were changed with graft check at four days and then twice weekly until completely healed.
Photographic records were taken at every intervention (Figs. 1, 2). The punch biopsy specimens of representative areas were taken at various intervals for culture. All subjects received standard physiotherapy scar treatment, which included compression garment therapy.
RESULTS

Patient Characteristics
Twenty adult patients aged between 18 and 86 years old (mean age 40.1±4) shown in Table 1 were enrolled in this study. Five out of 20 patients were female. Burn incidents had occurred mostly at work and home (45% and 40%, respectively). Seventy percent of the patients were in a closed area and were exposed to inhalation injuries. Full-thickness burn wounds covered 25%-96% of TBSA with a mean surface of 50.1%±2%. The mean surface receiving Nevelia ® was 8.25%±1% of TBSA (on third-degree burn area).
Nevelia® application
The colonisation of Nevelia ® and mean duration time for the STSG acceptance was 21.2±3 days. Other than two integration failure, no adverse event or complications related to the use of Nevelia ® were seen. Patients were discharged with a mean recovery of 55.2±4 days ( Table 2) .
Among the 20 patients, failure was seen in two patients who had DS Nevelia ® . These two cases had burn wound in 92% and 96% of their TBSA with multiple comorbidities. The clinical status of these two patients was critical, and they died from their injuries. Their wound healing was poor, probably because of multiorgan insufficiency.
DISCUSSION
Patients with severe full-thickness burn wounds require artificial materials due to the deprivation of sufficient donor tissue. Identifying efficient, safe and cost-effective skeleton materials can be stressful. Autologous skin graft is the most preferred material in burn wound coverage; however, especially in extensive full-thickness burn wounds, having limited donor sites can complicate the process. Another distressing point is the presence of donor tissue morbidities regarding having additional wounds and scars. This issue required various skin substitutes for the treatment of acute full-thickness burn wounds. [6] At present, there are numerous DS products available commercially. Most of these products have been extensively tested and examined in both pre-clinical and clinical settings. [7] [8] [9] [10] In the last 1-year period, we have applied Nevelia ® to several escharotomy areas of some of our severely burned patients.
Many of the present biocompatible DS can mimic the basic properties of the extracellular matrix in human skin by providing some structural integrity, elasticity and vascular bed. It reduces evaporative water loss, and the exudation of proteinrich fluids prevents wound desiccation and suppress micro-Yiğitbaş et al. Our experience with DS Nevelia® in the treatment of severely burned patients bial proliferation. However, these products lack the epithelial layer, and in most cases, the use of such products will generally be followed by the inoculation of the split-thickness skin autograft for permanent coverage in a two-step procedure. We applied a split-thickness skin autograft after a mean of 21.4 days from the application of Nevelia ® .
In severe burns, various options are available after the clinicians perform early escharotomy. These options include allograft usage, DS, keratinocyte autoculture or antimicrobial dressing material application. Allograft usage may pose problems because of rejection and infection. Antimicrobial dressing material application generally does not provide the patient with enough protection from bacteraemia. Keratinocyte autoculture has not progressed to qualify for routine clinical usage.
Identifying a successful material that will be helpful during the eschar management period is very important. In recent years, DS has played important roles in burn treatment protocols. After escharotomy, an effective DS is very helpful in building a protection cover for the body. If DS is effective, then, the survival percentage of the patient increases.
There is still a possibility of harvest morbidity that may be inadequate in donor sites in wide burn areas. As indicated in the literature, [11] the use of Nevelia ® allows us to harvest thinner split-thickness skin autografts and thus donor sites heal faster. These materials are also helpful in improving the elasticity of the skin after split-thickness skin graft application.
Despite the potential and need for DS, further research is required to strengthen the scientific evidence of the potential impacts and to develop new technologies and products. [12, 13] However, these substitutes have significant limitations when used in the presence of infections or full-thickness defects. [14] In our case series, integration failed only in two of the 20 cases. These two cases had burn wound in 92% and 96% of their TBSA and had many comorbidities. Their clinical status was critical, and they died from their injuries. Their wound healing was poor, probably due to multiorgan insufficiency.
DS appear as a key research strategy to improve sufficient scaffolds to obtain long-lasting and scarred artificial skin for stem cells, regenerative medicine applications and tissue engineering. [15, 16] Integra ® Dermal Regeneration Template (Integra Life Science, NJ, USA) is a widely used for covering excised full-thickness burn wounds and has proven to be particularly valuable in patients with large burns and limited autograft donor sites. [11, 17] Integra ® consists of the following two layers: a DS made of porous bovine collagen and chondroitin-6sulfate glycosaminoglycan and an epidermal substitute made of a synthetic silicone polymer. The dermal layer serves as a matrix for infiltration by fibroblasts and other cells from the wound bed. De Angelis B et al. reported that Nevelia ® had early regenerative properties in epidermal proliferation and dermal regeneration when compared with that of Integra. The study also showed that Nevelia ® revealed more pronounced angiogenesis against Integra ® , which was evaluated with α-SMA immunohistochemistry. [10] In the present study, we found good integration and wound healing process with Nevelia ® .
Conclusion
The findings of the present study provide favourable results of incorporating Nevelia ® in our daily practice for the treatment of severely burned patients. Authors conclude that Nevelia ® is safe as well as easy to use. Additionally, graft loss over Nevelia ® is unusual. 
